Behringwerke Aktiengesellschaft

Aventis Pharma Deutschland, Gmbh

Dade Behring Marburg Gmbh

Roland Kurrle

Karlheinz Enssle

Friedrich-Robert Seiler

Leander Lauffer

Klaus-Dieter Langner

Klaus Bosslet

Peter Hermentin

Hans H Sedlacek

Friedrich R Seiler

Hans U Schorlemmer

Reiner Donges

Ernst-Jurgen Kanzy

Takako Katoh

Gerhard Luben

Josef-Urban Pauly

The invention relates to a method for detecting and determining mediators and/or their derivatives in fluids, the mediator being detected directly or indirectly with the aid of a recombinant, soluble receptor for the mediator to be detected.

Method for detecting and determining mediators

Use of the IL-4 receptor for the therapy prophylaxis and diagnosis of allergic viral parasitic and bacterial diseases and of fungal infections

Monoclonal antibodies with specificity for membrane-associated antigens and methods of using them in detection of tumor-associated antigens arc described.

Monoclonal antibodies with specificity for membrane-associated antigens

The IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and of fungal infections. The invention relates to the il-4 receptor or variants thereof for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and of fungal infections.

IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, and bacterial diseases and of fungal infections

The invention relates to magnetic protein conjugates of the formula I ##STR1## in which M represents a dispersible magnetically reacting material or particle which carries aminogroups, Ig represents a protein which carries one or more mercapto groups, and X represents an organic chemical structure which links the two ligands by chemical means, to a process for the preparation of protein conjugates of the formula I, and to the use of conjugates of this type for removing cells or soluble bioorganic molecules or components from aqueous salt solutions or body fluids, and to the use thereof within the framework of a diagnostic method or as a diagnostic aid.

Magnetic protein conjugates, a process for the preparation thereof, and

The present invention relates to a composition containing the p40 subunit of interleukin-12, hereinafter referred to as p40/IL-12 and to methods of diagnosis and treatment of disorders associated with disregulation of the immune system.

Composition containing the P40 subunit of interleukin-12

Growing community of inventors

Niederweimar, Germany

Roland Kurrle